Regarding the biomarkers in hypertensive disorders of pregnancy (HDP) Soldavini et al. conducted a study and found that non-COVID-19 patients with HDP had significantly higher sFlt-1/PlGF ratios compared to both hypertensive and normotensive COVID-19 patients. Here, PGF is linked to COVID-19.